RedHill stock rises on expanded Medicare coverage
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Redhill Biopharma Ltd (RDHL)
Assess today's live Redhill Biopharma Ltd (RDHL) share price, performance and insights using our live NASDAQ: RDHL stock exchange data.
Analyse the historical data and Redhill Biopharma Ltd share price performance charts on this page. Our technical summary section provides analysis on Redhill ADR share price buy/sell indicators using real-time data (or discuss the Redhill ADR (RDHL) stock price today with other investors in the Redhill ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RDHL share price (ISIN: US7574683014) to enhance your trading decisions with our free investment tools and resources.
What Is the Redhill Biopharma Ltd Share Price Today?
The Redhill ADR share price today is 6.510.
What Is the Stock Symbol for Redhill Biopharma Ltd
The stock symbol (or 'ticker') for Redhill Biopharma Ltd is "RDHL."
What Stock Exchange Does Redhill Biopharma Ltd Trade On?
Redhill Biopharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Redhill Biopharma Ltd a Good Stock to Buy?
Determining whether Redhill Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Redhill Biopharma Ltd share price performance charts on this page. Our technical summary section provides analysis on Redhill ADR share price buy/sell indicators using real-time data (or discuss the Redhill ADR (RDHL) stock price today with other investors in the Redhill ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ RDHL share price (ISIN: US7574683014) to enhance your trading decisions with our free investment tools and resources.
What Is the Redhill Biopharma Ltd Share Price Today?
The Redhill ADR share price today is 6.510.
What Is the Stock Symbol for Redhill Biopharma Ltd
The stock symbol (or 'ticker') for Redhill Biopharma Ltd is "RDHL."
What Stock Exchange Does Redhill Biopharma Ltd Trade On?
Redhill Biopharma Ltd is listed and trades on the NASDAQ stock exchange.
Is Redhill Biopharma Ltd a Good Stock to Buy?
Determining whether Redhill Biopharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
6.510
+0.120(+1.88%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.330
6.630
52 wk Range
0.283
12.500
RDHL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6.3306.630
52 wk Range
0.28312.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
RDHL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- RedHill stock rises on expanded Medicare coverage
- Investing.com
- RedHill wins $8 million judgment in New York court
- Investing.com
Redhill ADR Company Profile
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers’ diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, advanced unresectable cholangiocarcinoma, prostate cancer, and nuclear radiation protection; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn’s disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 for pulmonary nontuberculous mycobacteria infections caused by mycobacterium avium complex. The company was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
Compare RDHL to Peers and Sector
Metrics to compare | RDHL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRDHLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −1.4x | −0.6x | |
PEG Ratio | 0.00 | −0.01 | 0.00 | |
Price/Book | 138.6x | 0.4x | 2.6x | |
Price / LTM Sales | 2.3x | 4.4x | 3.1x | |
Upside (Analyst Target) | - | 271.2% | 50.2% | |
Fair Value Upside | Unlock | 44.0% | 7.5% | Unlock |
Earnings
Latest Release
Nov 29, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Redhill ADR (RDHL) Stock Price Today?
The Redhill ADR stock price today is 6.51
What Stock Exchange Does Redhill ADR Trade On?
Redhill ADR is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Redhill ADR?
The stock symbol for Redhill ADR is "RDHL."
What Is the Redhill ADR Market Cap?
As of today, Redhill ADR market cap is 8.11M.
What is Redhill ADR Earnings Per Share?
The Redhill ADR EPS is -38.52.
What Is the Next Redhill ADR Earnings Date?
Redhill ADR will release its next earnings report on 13 Mar 2025.
From a Technical Analysis Perspective, Is RDHL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.